October 20, 2014 10:47 PM ET

Healthcare Equipment and Supplies

Company Overview of Henley Healthcare, Inc.

Company Overview

Henley Healthcare, Inc. develops, manufactures and distributes products and related accessories used in the control of acute or chronic pain. The company offers a diversified line of non-invasive physical medicine and rehabilitation products that are used in the treatment of disabilities or injuries with therapeutic exercise and the application of various heat, Fluidotherapy(R), traction, ultrasound or other modalities. Henley Healthcare's clinical unit manufactures pain management products used in clinical settings for physical therapy, rehabilitation and other applications. The company's training unit consists of Health Career Learning Systems, which provides training and safety products, ...

120 Industrial Boulevard

Sugar Land, TX 77478

United States

Founded in 1990

142 Employees

Phone:

281-276-7000

Fax:

281-276-7176

Key Executives for Henley Healthcare, Inc.

Chief Executive Officer and President
Chief Accounting Officer and Executive Vice President of Finance
Age: 63
Compensation as of Fiscal Year 2014.

Henley Healthcare, Inc. Key Developments

SEC Revokes Registration Of Securities Of Henley Healthcare

An Administrative Law Judge, acting pursuant to Section 12(j) of the Securities Exchange Act of 1934 (Exchange Act), issued an Order Making Finding and Revoking Registrations by Default as to Henley Healthcare, Inc. The default Order found that the company had securities registered with the Securities and Exchange Commission (SEC) pursuant to Section 12(g) of the Exchange Act and had failed to file the periodic reports required by Section 13(a) of the Exchange Act and Exchange Act Rules 13a-1 and 13a-13.

SEC Orders Hearing On Registration Suspension Or Revocation Against Henley Healthcare

On January 7, 2013, the Securities and Exchange Commission (SEC) instituted public administrative proceeding to determine whether to revoke or suspend for a period not exceeding twelve months the registrations of each class of the securities of Henley Healthcare, Inc. for failure to make required periodic filings with the Commission. In this Order, the Division of Enforcement (Division) alleges that the company is delinquent in its required periodic filings with the Commission. In this proceeding, instituted pursuant to Exchange Act Section 12(j), a hearing will be scheduled before an Administrative Law Judge. At the hearing, the Administrative Law Judge will hear evidence from the Division and the company to determine whether the allegations of the Division contained in the Order, which the Division alleges constitute failures to comply with Exchange Act Section 13(a) and Rules 13a-1 and 13a-13 there under, are true. The Administrative Law Judge in the proceeding will then determine whether the registrations pursuant to Exchange Act Section 12 of each class of the securities of the company should be revoked or suspended for a period not exceeding twelve months. The Commission ordered that the Administrative Law Judge in this proceeding issue an initial decision not later than 120 days from the date of service of the order instituting proceeding.

Similar Private Companies By Industry

Company Name Region
Meretek Diagnostics Group of Otsuka America Pharmaceutical, Inc. United States
BodyScan Corp. United States
SenDx Medical, Inc. United States
Draeger Medical, Inc. United States
Sheaumann Laser, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Henley Healthcare, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.